Information

We are a group of users focused on expanding the breadth and depth of Groovy and Grails development skills with our members who live and work in the DFW area. Our meetings are on the 1st Wednesday of every month (social & food at 6:30pm, meeting content at 7:00pm) at the NEW Improving office in Plano.

General Announcement

Starting with the June 2017 meeting we will be focusing on introducing new members to Groovy. We will have a series of talks that will bring them up to speed on Groovy, Gradle, Grails and application development. Please bring your friend, neighbor and co-worker, especially if they are familiar with Java, as the ramp-up is very easy.

Creative people have better-connected brains.

They found no statistical distinctions in connectivity within hemispheres, or between men and women. However when they likened individuals who have scored in the very best 15 % in the imagination lab tests with those in underneath 15 %, high-scoring people acquired a lot more contacts between your correct and remaining hemispheres. The differences were mainly within the brain’s frontal lobe. Dunson said their strategy may be utilized to predict the possibility a person is going to be highly creative simply predicated on his / her human brain network framework. Probably by scanning someone’s human brain we could inform what they’re apt to be proficient at, Dunson stated. The scholarly study is section of a decade-old field, connectomics, which uses network science to comprehend the brain.Meals and Medication Administration notified the firms that it needs more time to examine the marketing software for his or her uterine pain medication. FILE Image: A display displays the talk about cost for pharmaceutical manufacturer AbbVie on to the floor of the brand new York STOCK MARKET July 18, 2014. REUTERS/Brendan McDermidThe company requested additional time to review more information regarding the outcomes of liver organ function tests supplied by AbbVie regarding the the application form for Elagolix in endometriosis-associated discomfort, the ongoing companies said. The FDA is currently expected to help to make its decision in the 3rd quarter of 2018, 90 days later on than initially expected.